Blocking an N-terminal acetylation-dependent protein interaction inhibits an E3 ligase Journal Article


Authors: Scott, D. C.; Hammill, J. T.; Min, J.; Rhee, D. Y.; Connelly, M.; Sviderskiy, V. O.; Bhasin, D.; Chen, Y.; Ong, S. S.; Chai, S. C.; Goktug, A. N.; Huang, G.; Monda, J. K.; Low, J.; Kim, H. S.; Paulo, J. A.; Cannon, J. R.; Shelat, A. A.; Chen, T.; Kelsall, I. R.; Alpi, A. F.; Pagala, V.; Wang, X.; Peng, J.; Singh, B.; Harper, J. W.; Schulman, B. A.; Guy, R. K.
Article Title: Blocking an N-terminal acetylation-dependent protein interaction inhibits an E3 ligase
Abstract: N-terminal acetylation is an abundant modification influencing protein functions. Because ∼80% of mammalian cytosolic proteins are N-terminally acetylated, this modification is potentially an untapped target for chemical control of their functions. Structural studies have revealed that, like lysine acetylation, N-terminal acetylation converts a positively charged amine into a hydrophobic handle that mediates protein interactions; hence, this modification may be a druggable target. We report the development of chemical probes targeting the N-terminal acetylation-dependent interaction between an E2 conjugating enzyme (UBE2M or UBC12) and DCN1 (DCUN1D1), a subunit of a multiprotein E3 ligase for the ubiquitin-like protein NEDD8. The inhibitors are highly selective with respect to other protein acetyl-amide-binding sites, inhibit NEDD8 ligation in vitro and in cells, and suppress anchorage-independent growth of a cell line with DCN1 amplification. Overall, our data demonstrate that N-terminal acetyl-dependent protein interactions are druggable targets and provide insights into targeting multiprotein E2-E3 ligases. © 2017 Nature America, Inc., part of Springer Nature. All rights reserved.
Keywords: unclassified drug; human cell; dose response; ubiquitin; metabolism; ubiquitin protein ligase; protein interaction; in vitro study; dose-response relationship, drug; enzyme inhibitor; molecular library; small molecule libraries; structure activity relation; structure-activity relationship; chemistry; amino terminal sequence; enzyme inhibitors; fluorescence resonance energy transfer; binding site; hydrogen bond; models, molecular; isoleucine; threonine; binding sites; chemical structure; molecular structure; alanine; leucine; ubiquitin protein ligase e3; ubiquitin-protein ligases; glycine; molecular model; binding competition; valine; pharmacology; acetylation; ubiquitins; ubiquitin protein ligase e2; neddylation; protein acetylation; drug effects; nedd8 protein; humans; human; priority journal; article; antagonists and inhibitors; dcn1 protein; dcn2 protein; dcn3 protein; dcn4 protein; ube2m protein; nedd8 protein, human; hcc95 cell line
Journal Title: Nature Chemical Biology
Volume: 13
Issue: 8
ISSN: 1552-4450
Publisher: Nature Publishing Group  
Date Published: 2017-08-01
Start Page: 850
End Page: 857
Language: English
DOI: 10.1038/nchembio.2386
PUBMED: 28581483
PROVIDER: scopus
PMCID: PMC5577376
DOI/URL:
Notes: Article -- Export Date: 2 October 2017 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Bhuvanesh Singh
    242 Singh
  2. Guochang Huang
    15 Huang